Publication | Closed Access

Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients

Future DiscontinuationHematological MalignancyOncologyMedicinePatient-based SurveyMixed-phenotype Acute LeukemiaHematologyMalignant Blood DisorderTyrosine Kinase InhibitorsPharmacotherapyPharmacologyTherapy ResistanceMyeloid Neoplasia